207 related articles for article (PubMed ID: 36661705)
1. Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review.
Zeng XL; Heneghan MB; Badawy SM
Curr Oncol; 2023 Jan; 30(1):720-748. PubMed ID: 36661705
[TBL] [Abstract][Full Text] [Related]
2. Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1.
Hoppmann AL; Chen Y; Landier W; Hageman L; Evans WE; Wong FL; Relling MV; Bhatia S
Cancer; 2021 Oct; 127(20):3832-3839. PubMed ID: 34161608
[TBL] [Abstract][Full Text] [Related]
3. Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.
Kahn JM; Stevenson K; Beauchemin M; Koch VB; Cole PD; Welch JJG; Gage-Bouchard E; Karsenty C; Silverman LB; Kelly KM; Bona K
J Pediatr Hematol Oncol Nurs; 2023; 40(1):17-23. PubMed ID: 36221984
[No Abstract] [Full Text] [Related]
4. Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis.
Wu YP; Stenehjem DD; Linder LA; Yu B; Parsons BG; Mooney R; Fluchel MN
J Pediatr Oncol Nurs; 2018; 35(2):86-93. PubMed ID: 29188741
[TBL] [Abstract][Full Text] [Related]
5. A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia.
Landier W; Hughes CB; Calvillo ER; Anderson NL; Briseño-Toomey D; Dominguez L; Martinez AM; Hanby C; Bhatia S
J Pediatr Oncol Nurs; 2011; 28(4):203-23. PubMed ID: 21653911
[TBL] [Abstract][Full Text] [Related]
6. Optimizing medication adherence in children with cancer.
Gupta S; Bhatia S
Curr Opin Pediatr; 2017 Feb; 29(1):41-45. PubMed ID: 27798425
[TBL] [Abstract][Full Text] [Related]
7. Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.
Bhatia S; Landier W; Hageman L; Chen Y; Kim H; Sun CL; Kornegay N; Evans WE; Angiolillo AL; Bostrom B; Casillas J; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Wong FL; Relling MV
JAMA Oncol; 2015 Jun; 1(3):287-95. PubMed ID: 26181173
[TBL] [Abstract][Full Text] [Related]
8. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.
Bhatia S; Landier W; Shangguan M; Hageman L; Schaible AN; Carter AR; Hanby CL; Leisenring W; Yasui Y; Kornegay NM; Mascarenhas L; Ritchey AK; Casillas JN; Dickens DS; Meza J; Carroll WL; Relling MV; Wong FL
J Clin Oncol; 2012 Jun; 30(17):2094-101. PubMed ID: 22564992
[TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia: are Egyptian children adherent to maintenance therapy?
Khalek ER; Sherif LM; Kamal NM; Gharib AF; Shawky HM
J Cancer Res Ther; 2015; 11(1):54-8. PubMed ID: 25879337
[TBL] [Abstract][Full Text] [Related]
10. 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.
Bhatia S; Landier W; Hageman L; Kim H; Chen Y; Crews KR; Evans WE; Bostrom B; Casillas J; Dickens DS; Maloney KW; Neglia JP; Ravindranath Y; Ritchey AK; Wong FL; Relling MV
Blood; 2014 Oct; 124(15):2345-53. PubMed ID: 24829202
[TBL] [Abstract][Full Text] [Related]
11. Electronic monitoring of medication adherence in early maintenance phase treatment for pediatric leukemia and lymphoma: identifying patterns of nonadherence.
Rohan JM; Drotar D; Alderfer M; Donewar CW; Ewing L; Katz ER; Muriel A
J Pediatr Psychol; 2015; 40(1):75-84. PubMed ID: 24365698
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract][Full Text] [Related]
13. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
Festa RS; Tamaroff MH; Chasalow F; Lanzkowsky P
J Pediatr; 1992 May; 120(5):807-11. PubMed ID: 1533662
[TBL] [Abstract][Full Text] [Related]
15. Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review.
Pritchard MT; Butow PN; Stevens MM; Duley JA
J Pediatr Hematol Oncol; 2006 Dec; 28(12):816-23. PubMed ID: 17164651
[TBL] [Abstract][Full Text] [Related]
16. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S
J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328
[TBL] [Abstract][Full Text] [Related]
17. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
Lukenbill J; Advani AS
Curr Hematol Malig Rep; 2013 Jun; 8(2):91-7. PubMed ID: 23559026
[TBL] [Abstract][Full Text] [Related]
18. A home-based maintenance therapy program for acute lymphoblastic leukemia-practical and safe?
Phillips B; Richards M; Boys R; Hodgkin M; Kinsey S
J Pediatr Hematol Oncol; 2011 Aug; 33(6):433-6. PubMed ID: 21646916
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of parents of pediatric patients with acute lymphoblastic leukemia on oral chemotherapy administration: A qualitative analysis.
Tang N; Kovacevic A; Zupanec S; Sivananthan A; Patel R; Patel P; Vennettilli A; Paw Cho Sing E; Alexander S; Sung L; Dupuis LL
Pediatr Blood Cancer; 2022 Jan; 69(1):e29329. PubMed ID: 34492743
[TBL] [Abstract][Full Text] [Related]
20. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
